Clinical Trials Directory

Trials / Completed

CompletedNCT01303068

Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF

Detection of Pseudomonas. Aeruginosa in the Airways of Patients With Cystic Fibrosis Using of Aerosolized 13C-urea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if inhaled urea can be used to detect the presence of Pseudomonas Aeruginosa in the lungs

Detailed description

Dose Escalation study

Conditions

Interventions

TypeNameDescription
DEVICE13C urea breath test Kit20 and 50 mg, 13C urea breath test: urea nebulizer solution to detect Pseudomonas

Timeline

Start date
2012-08-15
Primary completion
2014-08-01
Completion
2015-08-01
First posted
2011-02-24
Last updated
2024-01-30
Results posted
2021-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01303068. Inclusion in this directory is not an endorsement.

Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF (NCT01303068) · Clinical Trials Directory